It's
a wish list that India Inc. will give an arm and a leg to see
fulfilled. It's also a wish list that will involve hard negotiations,
backroom deals and, probably, some arm-twisting. Indian industry
wants easier access for its goods, services and personnel into
developed markets. The platform: the WTO (World Trade Organization)
Ministerial Negotiations in Hong Kong this December.
Agriculture remains the biggest stumbling
block in the talks between the developed and developing countries.
India wants access for its farm products and cuts in subsidies
that the West gives its farmers. But progress on the talks is
slow.
The services sector is praying hard for some
commitment from the developed world on Mode IV, which allows professionals
to move freely across countries, unfettered by things like H1B
visas. "Professionals wanting to travel abroad for work need
to be treated differently from general immigration," says
Sunil Mehta, Vice President, NASSCOM.
Indian industry also wants the issue of non-tariff
barriers, a.k.a. sanitary and phytosanitary (SPS), sorted out.
The chemicals and food processing industries and the agricultural
sector, in particular, are demanding amendments, or at least authorised
interpretations, of the SPS Agreement so that individual countries
can't set arbitrary standards. The demand is much the same in
textiles: lower tariff barriers and greater market access.
Rafeeq Ahmed, former President, FIEO, says
Indian businesses are willing to accept ASEAN tariff levels of
10 per cent on finished goods and 5 per cent on raw materials
in return for concessions on non-tariff barriers. But will the
West cede ground? Watch this space.
-Ashish Gupta
TEXTILES
»
Negotiate to see that rules of origin are not changed
to stop Indian exports
» No
preferential treatment for countries within various regional trade
blocs
»
Easier customs and administrative clearances at various ports
and airports
» Delink
exports from labour and environmental issues
»
Stop EU from imposing anti-dumping and anti-subsidy duties on
Indian linen
CHEMICALS
»
Ensure uniformity in regulatory norms and risk assessment
requirements
» Fight
unilateral SPS conditions imposed by the developed countries
»
Negotiate against unjustifiably high standards of EU chemical
regulations
»
Fight questionable standards on quarantine restrictions
» Fight
unnecessary restrictions on the use of certain chemicals
FOOD PROCESSING
»
Prevent unilateral imposition of standards that restrict
market access
» Delink
condition of workers and other social issues from exports
»
Ensure exports of eggs, meat and meat products to the European
Union
» Ensure
exports of fruits and vegetables to China and Japan
» Amend
the SPS Agreement to prevent its misuse as a non-tariff barrier
AUTOMOBILES & COMPONENTS
»
Ensure homogeneity on emission, noise and safety standards
all over the world
» Ensure
transparent customs norms in countries such as Chile and Argentina
»
Ensure protection of intellectual property rights in China
» Remove
investment and customs restrictions in China and Malaysia
» Ban
imports of re-manufactured and used vehicles and components
A
New Drug Order
Capping drug prices may not be the best thing
to do.
The rough ride
continues for the Indian pharmaceutical industry. Close on the
heels of the MRP-linked excise duties and the implementation of
value-added tax in some states, comes another big air pocket in
the form of the recommendations of the Pronab Sen Task Force on
Drug Pricing.
The task force wants 246 new drugs, including
those under patents, to be added to the list of 39 currently under
price control. Interpretation: the reference point for patented
drug prices will either be their international prices or the price
of their therapeutic equivalents in India. The rationale: affordability.
The flip side: corporate margins will be hit.
THE RECOMMENDATIONS |
»
246 new drugs to be brought under the price control
net
»
Begin a time-bound process for de-branding of drugs
»
Settlement Commission to review and resolve all DPCO cases
»
Replacing the DPCO by a new Drugs (Price Regulation and
Monitoring) Act
» Replace
criminal liability with punitive penalty for all offences
|
The draft also talks of a time-bound process
to de-brand "select'' drugs. These drugs, henceforth, will
only carry the API (active pharmaceutical ingredient) and the
name of the manufacturer. And doctors will be asked to prescribe
generic drugs rather than brands so that the man on the street
is not forced to fork out huge premiums that companies charge
for certain brands. There's also a proposal to give the government
greater control over the pricing and monitoring of drugs.
The proposed Settlement Commission, however,
is expected to lead to a quicker disposal of price-related disputes
between the government and industry.
The industry is expected to give its views
on the draft in the second week of September. It will be implemented
only after suitable amendments are incorporated.
-Ashish Gupta
Championing Consolidation
The Finance Minister wants more mergers among
public sector banks,
but RBI is dragging its feet.
|
|
Keeping mum: FM Chidambaram
(left) and RBI Governor Y.V. Reddy |
Finance minister
P. Chidambaram is keen to push through consolidation in the banking
sector. He said as much at the annual general meeting of the Indian
Banks' Association in Mumbai in the last week of August. And with
good reason!
Basel II norms will be introduced in the
country next year. Banks will then have to set aside capital not
only for credit and market risks, but also for risks arising out
of internal deficiencies. The tab, according to Ashvin Parekh,
National Leader (Financial Services), Ernst & Young, will
be Rs 25,000 crore. "Basel II will be highly capital intensive
and the Indian banking industry will need Rs 25,000 crore between
2007 and 2010,'' he says. As public sector banks still dominate
the Indian banking industry-they make up more than 80 per cent
of it-Chidambaram could be forced to cough up around Rs 20,000
crore to meet the new norms.
It won't be easy to find so much money, not
unless there is consolidation in the public sector banking industry.
The logic is simple: larger banks can be expected to have stronger
balance sheets, making it easier for them to raise funds from
private investors. Also, the merger of weaker banks with the stronger
ones will obviate the need for the government to bail them out,
should they get into trouble.
But the Rs 20,000-crore question is: will
consolidation happen? Despite Chidambaram's enthusiasm, the proposal
to merge Union Bank of India and the Bank of India has been hanging
fire for a year. His ministry has not sought parliamentary approval,
a mandatory requirement for the merger of public sector banks,
for the same. The Reserve Bank of India, too, has yet to announce
any guidelines on such mergers.
Meanwhile, the Basel II deadline nears.
-Ashish Gupta
|